tiprankstipranks
Aditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
PremiumThe FlyAditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
3M ago
Appili Therapeutics’ FDA Alignment and Aditxt Acquisition
Premium
Company Announcements
Appili Therapeutics’ FDA Alignment and Aditxt Acquisition
3M ago
Appili Therapeutics announces FDA alignment on ATI-1801 NDA requirements
Premium
The Fly
Appili Therapeutics announces FDA alignment on ATI-1801 NDA requirements
3M ago
Appili Therapeutics mails circular in connection with special meeting
PremiumThe FlyAppili Therapeutics mails circular in connection with special meeting
4M ago
Appili Therapeutics Shareholders Back Key Resolutions
Premium
Company Announcements
Appili Therapeutics Shareholders Back Key Resolutions
5M ago
Appili Therapeutics Modifies Acquisition Deal with Aditxt
Premium
Company Announcements
Appili Therapeutics Modifies Acquisition Deal with Aditxt
5M ago
APLIF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsAPLIF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
Appili Therapeutics Secures Bridge Financing
Premium
Company Announcements
Appili Therapeutics Secures Bridge Financing
9M ago
Aditxt  in pact to acquire Appili Therapeutics for 5.6c per share
Premium
The Fly
Aditxt in pact to acquire Appili Therapeutics for 5.6c per share
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100